UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways

Endocrine-related cancer, 2012-06, Vol.19 (3), p.305-319

2012

Volltextzugriff (PDF)

Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor

Endocrine-related cancer, 2009-03, Vol.16 (1), p.155-169

2009

Volltextzugriff (PDF)

Down-regulation of Suppressor of Cytokine Signaling-3 Causes Prostate Cancer Cell Death through Activation of the Extrinsic and Intrinsic Apoptosis Pathways

Cancer research (Chicago, Ill.), 2009-09, Vol.69 (18), p.7375-7384

2009

Volltextzugriff (PDF)

Expression and function of androgen receptor coactivators in prostate cancer

The Journal of steroid biochemistry and molecular biology, 2004-11, Vol.92 (4), p.265-271

2004

Volltextzugriff (PDF)

Suppressor of Cytokine Signaling (SOCS)-1 Is Expressed in Human Prostate Cancer and Exerts Growth-Inhibitory Function through Down-Regulation of Cyclins and Cyclin-Dependent Kinases

The American journal of pathology, 2009-05, Vol.174 (5), p.1921-1930

2009

Volltextzugriff (PDF)

Androgen deprivation increases p300 expression in prostate cancer cells

Cancer research (Chicago, Ill.), 2007-04, Vol.67 (7), p.3422-3430

2007

Volltextzugriff (PDF)

SOCS-3 antagonises the proliferative and migratory effects of fibroblast growth factor-2 in prostate cancer by inhibition of p44/p42 MAPK signalling

Endocrine-related cancer, 2010-06, Vol.17 (2), p.525-538

2010

Volltextzugriff (PDF)

The androgen receptor co-activator CBP is up-regulated following androgen withdrawal and is highly expressed in advanced prostate cancer

The Journal of pathology, 2004-10, Vol.204 (2), p.159-166

2004

Volltextzugriff (PDF)

Suppressor of cytokine signalling-3 is up-regulated by androgen in prostate cancer cell lines and inhibits androgen-mediated proliferation and secretion

Endocrine-related cancer, 2007-12, Vol.14 (4), p.1007-1019

2007

Volltextzugriff (PDF)

Prostate Cancer Cells (LNCaP) Generated after Long-Term Interleukin 6 (IL-6) Treatment Express IL-6 and Acquire an IL-6 Partially Resistant Phenotype

Clinical cancer research, 2001-09, Vol.7 (9), p.2941-2948

2001

Volltextzugriff (PDF)

Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue

The Journal of pathology, 2000-07, Vol.191 (3), p.239-244

2000

Volltextzugriff (PDF)

Interleukin-6 and oncostatin M stimulation of proliferation of prostate cancer 22Rv1 cells through the signaling pathways of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase

The Prostate, 2005-07, Vol.64 (2), p.209-216

2005

Volltextzugriff (PDF)

Regulation of prostatic growth and function by peptide growth factors

The Prostate, 1996-06, Vol.28 (6), p.392-405

1996

Volltextzugriff (PDF)

Interleukin-6 regulation of prostate cancer cell growth

Journal of cellular biochemistry, 2005-06, Vol.95 (3), p.497-505

2005

Volltextzugriff (PDF)

Single institution experience with the transobturator sling suspension system AdVance® in the treatment of male urinary incontinence: mid-term results

International Brazilian journal of urology, 2011-08, Vol.37 (4), p.488-494

2011

Volltextzugriff (PDF)

Acquisition of Agonistic Properties of Nonsteroidal Antiandrogens after Treatment with Oncostatin M in Prostate Cancer Cells

Clinical cancer research, 2002-07, Vol.8 (7), p.2356-2361

2002

Volltextzugriff (PDF)

Detection and Clinical Outcome of Urinary Bladder Cancer With 5-Aminolevulinic Acid-Induced Fluorescence Cystoscopy: A Multicenter Randomized, Double-Blind, Placebo-Controlled Trial

Cancer, 2011-03, Vol.117 (5), p.938-947

2011

Volltextzugriff (PDF)

Expression, structure, and function of androgen receptor in advanced prostatic carcinoma

The Prostate, 1998-04, Vol.35 (1), p.63-70

1998

Volltextzugriff (PDF)

Retroperitoneal Lymphadenectomy for Clinical Stage I Nonseminomatous Testicular Tumor: Laparoscopy Versus Open Surgery and Impact of Learning Curve

The Journal of urology, 1996-07, Vol.156 (1), p.89-94

1996

Volltextzugriff (PDF)

Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth

Molecular and Cellular Endocrinology, 2002-11, Vol.197 (1), p.231-238

2002

Volltextzugriff (PDF)

Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor

Cancer research (Chicago, Ill.), 1998-10, Vol.58 (20), p.4640-4645

1998

Volltextzugriff (PDF)

Posttraumatic High-Flow Priapism in Children: Noninvasive Treatment by Color Doppler Ultrasound-Guided Perineal Compression

Urology (Ridgewood, N.J.), 2007-09, Vol.70 (3), p.590.e3-590.e5

2007

Volltextzugriff (PDF)

Long-term results of laparoscopic retroperitoneal lymph node dissection: a single-center 10-year experience

Urology (Ridgewood, N.J.), 2004-03, Vol.63 (3), p.550-555

2004

Volltextzugriff (PDF)

Androgen Receptors in Prostate Cancer

The Journal of urology, 2003-10, Vol.170 (4), p.1363-1369

2003

Volltextzugriff (PDF)

Interleukin-6 and prostate cancer progression

Cytokine & growth factor reviews, 2001-03, Vol.12 (1), p.33-40

2001

Volltextzugriff (PDF)

1 – 25 von 128

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(114)
Mit Volltextzugriff
(90)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways

Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor

Down-regulation of Suppressor of Cytokine Signaling-3 Causes Prostate Cancer Cell Death through Activation of the Extrinsic and Intrinsic Apoptosis Pathways

Expression and function of androgen receptor coactivators in prostate cancer

Suppressor of Cytokine Signaling (SOCS)-1 Is Expressed in Human Prostate Cancer and Exerts Growth-Inhibitory Function through Down-Regulation of Cyclins and Cyclin-Dependent Kinases

Androgen deprivation increases p300 expression in prostate cancer cells

SOCS-3 antagonises the proliferative and migratory effects of fibroblast growth factor-2 in prostate cancer by inhibition of p44/p42 MAPK signalling

The androgen receptor co-activator CBP is up-regulated following androgen withdrawal and is highly expressed in advanced prostate cancer

Suppressor of cytokine signalling-3 is up-regulated by androgen in prostate cancer cell lines and inhibits androgen-mediated proliferation and secretion

Prostate Cancer Cells (LNCaP) Generated after Long-Term Interleukin 6 (IL-6) Treatment Express IL-6 and Acquire an IL-6 Partially Resistant Phenotype

Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue

Interleukin-6 and oncostatin M stimulation of proliferation of prostate cancer 22Rv1 cells through the signaling pathways of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase

Regulation of prostatic growth and function by peptide growth factors

Interleukin-6 regulation of prostate cancer cell growth

Single institution experience with the transobturator sling suspension system AdVance® in the treatment of male urinary incontinence: mid-term results

Acquisition of Agonistic Properties of Nonsteroidal Antiandrogens after Treatment with Oncostatin M in Prostate Cancer Cells

Detection and Clinical Outcome of Urinary Bladder Cancer With 5-Aminolevulinic Acid-Induced Fluorescence Cystoscopy: A Multicenter Randomized, Double-Blind, Placebo-Controlled Trial

Expression, structure, and function of androgen receptor in advanced prostatic carcinoma

Retroperitoneal Lymphadenectomy for Clinical Stage I Nonseminomatous Testicular Tumor: Laparoscopy Versus Open Surgery and Impact of Learning Curve

Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth

Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor

Posttraumatic High-Flow Priapism in Children: Noninvasive Treatment by Color Doppler Ultrasound-Guided Perineal Compression

Long-term results of laparoscopic retroperitoneal lymph node dissection: a single-center 10-year experience

Androgen Receptors in Prostate Cancer

Interleukin-6 and prostate cancer progression

Suchergebnisse filtern